Narayana Health Releases Revised Q2 FY27 Investor Presentation
Narayana Health's revised Q2 FY27 investor presentation shows consolidated revenue of ₹2844 crore, up 73% YoY. EBITDA was ₹605.4 crore (21.3% margin), and PAT was ₹301.2 crore (10.6% margin). The company highlighted clinical advancements and outlined a capex strategy for expansion, with significant investments planned.
The release of a revised investor presentation detailing strong financial results, clinical advancements, and future growth strategies has a significant impact on investors and stakeholders.
The announcement includes strong YoY growth in revenue and profits, alongside significant clinical achievements and strategic expansion plans, indicating positive performance and future outlook.
Narayana Hrudayalaya Ltd. has submitted a revised Investor Presentation for the quarter and half-year ended September 30, 2026. The presentation details operational and financial performance, including significant clinical achievements and expansion plans.
Key highlights for Q2 FY27 include consolidated operating revenues of ₹28,440 million (₹2844 crore), a year-over-year increase of 73.0% and a quarter-over-quarter increase of 6.0%. Consolidated EBITDA stood at ₹6,054 million (₹605.4 crore) with a margin of 21.3%, and Consolidated Profit After Tax (PAT) was ₹3,012 million (₹301.2 crore) with a margin of 10.6%. The company's net debt to equity ratio was 0.38 as of September 30, 2026.
The presentation also covers the company's expanding footprint across India and internationally, detailing facility numbers and bed capacities. Clinical achievements highlighted include South India's first Percutaneous Transcatheter Tricuspid Valve Replacement (TTVR) and India's first Transcatheter Tricuspid Valve Implantation (TTVI) performed at Narayana Institute of Cardiac Sciences, Bengaluru.
Future growth strategies include significant capital expenditure for new greenfield projects and expansions in key regions like Bangalore and Kolkata, with project completion targeted between FY28 and FY30. The company is also focusing on digital initiatives to enhance patient experience and streamline operations across its facilities.
Narayana Health's ESG vision, 'Health For All', outlines commitments to improving access to care, fostering innovation, and environmental sustainability. The presentation also includes the shareholding pattern as of September 30, 2026.
What to do with a filing like this
Narayana Hrudayalaya Ltd. filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Narayana Hrudayalaya Ltd.. Read the original for the full detail.